Tone mix
Week by week 50 weeks
Share of TG Therapeutics, Inc.'s 128 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Feb 16, 2026 · tone -100TG Therapeutics (NASDAQ:TGTX) Cut to "Hold" at Wall Street Zen-114
- Week of Aug 31, 2026 · tone +100TG Therapeutics' (TGTX) Buy Rating Reaffirmed at HC Wainwright+109
- Week of Jul 13, 2026 · tone -50TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations-91
- Week of Sep 15, 2025 · tone +100TG Therapeutics, Inc. (TGTX) Stock Analysis: Biotech Growth Potential With 25.93% Upside+89
- Week of Sep 1, 2025 · tone +87TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback+83
- Week of Mar 16, 2026 · tone +99TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million+79
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about TG Therapeutics, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | +89 |
| Last 30 sessions | 7 | +13 |
| Last 90 sessions | 33 | 0 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone +89: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.chathamdailynews.ca · 10 outletsTG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026 | www.chathamdailynews.ca | 10 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 8, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.nugget.ca · 3 outletsTG Therapeutics Announces Schedule of Data Presentations at MSToronto2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 | www.nugget.ca | 3 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 2, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletReviewing TG Therapeutics (NASDAQ:TGTX) & Aurinia Pharmaceuticals (NASDAQ:AUPH)Neutral
- www.tickerreport.com · 1 outletTG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Hold" from BrokeragesNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Reviewing TG Therapeutics (NASDAQ:TGTX) & Aurinia Pharmaceuticals (NASDAQ:AUPH) | www.themarketsdaily.com | 1 | Neutral |
| TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Hold" from Brokerages | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 1, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletHead-To-Head Review: TG Therapeutics (NASDAQ:TGTX) versus Puma Biotechnology (NASDAQ:PBYI)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Review: TG Therapeutics (NASDAQ:TGTX) versus Puma Biotechnology (NASDAQ:PBYI) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, September 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.prnewswire.com · 2 outletsKuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law FirmNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm | www.prnewswire.com | 2 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about TG Therapeutics, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.